Efficacy and Safety Study of Moxidectin in Adults with Scabies
- Conditions
- Scabies
- Interventions
- Drug: PlaceboDrug: Moxidectin Oral Product
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Medicines Development for Global Health
- Target Recruit Count
- 200
- Registration Number
- NCT05875441
- Locations
- 🇺🇸
LA Universal Research Center, Inc, Los Angeles, California, United States
🇺🇸Evolution Clinical Trials, Miami, Florida, United States
🇺🇸Medical Research of Westchester, Inc, Miami, Florida, United States
Safety of a Single Dose of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Albendazole
- Conditions
- Onchocerciasis
- Interventions
- First Posted Date
- 2020-03-17
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Medicines Development for Global Health
- Target Recruit Count
- 12997
- Registration Number
- NCT04311671
- Locations
- 🇨🇩
Centre de Recherche pour les Maladies Tropicales Negligees, Rethy, Ituri, Congo, The Democratic Republic of the
🇨🇮Centre Suisse de Recherches Scientifiques en Coˆte d'Ivoire, Abidjan, Côte D'Ivoire
A Pharmacokinetic and Safety Study of Moxidectin to Identify an Optimal Dose for Treatment of Children 4 to 11 Years
- First Posted Date
- 2019-05-23
- Last Posted Date
- 2022-12-15
- Lead Sponsor
- Medicines Development for Global Health
- Target Recruit Count
- 36
- Registration Number
- NCT03962062
- Locations
- 🇬ðŸ‡
University of Health and Allied Services School of Public Health, Hohoe, Volta Region, Ghana
Dose-finding Study of Moxidectin for Treatment of Scabies
- First Posted Date
- 2019-04-05
- Last Posted Date
- 2023-09-22
- Lead Sponsor
- Medicines Development for Global Health
- Target Recruit Count
- 22
- Registration Number
- NCT03905265
- Locations
- 🇫🇷
Hopital Henri Mondor AP-HP, Créteil, France
🇦🇹Medizinischen Universität Wien, Vienna, Austria
🇫🇷CHU Nice Hopital Archet 2, Nice, France
Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis
- First Posted Date
- 2019-03-15
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Medicines Development for Global Health
- Target Recruit Count
- 323
- Registration Number
- NCT03876262
- Locations
- 🇨🇩
Centre de Recherche pour les Maladies Tropicales Negligees, Rethy, Ituri, Congo, The Democratic Republic of the
Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers
- Conditions
- QT Effects in Healthy Volunteers
- Interventions
- Other: PlaceboDrug: Moxidectin
- First Posted Date
- 2017-01-06
- Last Posted Date
- 2019-03-14
- Lead Sponsor
- Medicines Development for Global Health
- Target Recruit Count
- 60
- Registration Number
- NCT03012828
- Locations
- 🇺🇸
Spaulding Clinical, West Bend, Wisconsin, United States
A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People
- Conditions
- HIV Infections
- Interventions
- Other: Dimethyl SulfoxideBiological: Opal-HIV-Gag(c) Low DoseBiological: Opal-HIV-Gag(c) Medium doseBiological: Opal-HIV-Gag(c) High dose
- First Posted Date
- 2010-05-14
- Last Posted Date
- 2018-03-22
- Lead Sponsor
- Medicines Development for Global Health
- Target Recruit Count
- 22
- Registration Number
- NCT01123915
- Locations
- 🇬🇧
St Stephen's Centre, Chelsea and Westminster Foundation Trust, London, United Kingdom
Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection
- First Posted Date
- 2008-11-14
- Last Posted Date
- 2018-01-31
- Lead Sponsor
- Medicines Development for Global Health
- Target Recruit Count
- 1497
- Registration Number
- NCT00790998
- Locations
- 🇨🇩
Centre de Recherche en Maladies Tropicales de l'Ituri, Rethy, Congo, The Democratic Republic of the
🇱🇷Liberian Institute for Biomedical Research Clinical Research Center, Bolahun, Lofa County, Liberia
🇨🇩Centre de Recherche Clinique de Butembo - Université Catholique du Graben, Butembo, Congo, The Democratic Republic of the
Study Evaluating Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection
- Conditions
- Onchocerciasis
- Interventions
- First Posted Date
- 2006-03-09
- Last Posted Date
- 2022-12-15
- Lead Sponsor
- Medicines Development for Global Health
- Target Recruit Count
- 172
- Registration Number
- NCT00300768
- Locations
- 🇬ðŸ‡
Onchocerciasis Chemotherapy Research Center, Hohoe, Volta Region, Ghana